Support

Support Options

Report a problem

About you
This is a randomly generated image of letters and numbers. Letters not clear? Click to renew CAPTCHA.
About the problem

Lijun Zhang

Profile

  • What is the best web address for people to learn more about you?

  • What would you like us to know about you?

    I am assistant professor in the Institute for Personalized Medicine (IPM), the Dept. of Biochemistry and Molecular Biology, at the College of Medicine of Pennsylvania State University (PSU-COM), focusing on neuroimaging and next generation sequence high dimensional data research. Before joined IPM, I worked in Dr. Xuemei Huang’s Hershey Brain Analysis Research Laboratory (HBAR), in the Dept. of Neurology at the PSU Hershey Medical Center, and focused on multi-modality neuroimging (T1, T2, R2, DTI, and fMRI) studies on neurodegenerative disease, special on Parkinson’s Disease (PD). Previously, I had worked four years in the Center for Biomedical Imaging Statistics (CBIS) in the Dept. of Biostatistics and Bioinformatics at Emory University with Dr. DuBois Bowman. Both my research focus on computational and statistical methodology and analysis on high-dimensional biomedical data (fMRI, DTI, PET, T1 and SNP), such as developing statistical and computational methods to characterize brain dynamic network and biomarkers in distributed brain neural processing associated with disorder disease, for example, Schizophrenia, Depression, Alzheimer, and Parkinson’s disease. I have Ph.D. in Computer Science and Computer Engineering, where my research spanned the areas of machine learning, pattern recognition, image processing, and information fusion. 


  • Where do you work?
    Penn State Unversity, College of Medicine

  • ORCiD
    (not set)

  • Phone Number
    (not set)

  • Twitter
    (not set)

  • Receive Email Updates
    Yes, send me emails

The opinions, findings, and conclusions or recommendations expressed on this site are those of the author(s) and do not necessarily reflect the views of Knowinnovation Inc.